Israel’s NovellusDx (see Jun 2016) has received a $900,000 BIRD Foundation award to identify and design personalized cancer therapies for the Delaware-based Gene Editing Institute. NovellusDx also won 1st prize in the international Quality Innovation Award competition.

http://www.phillyisraelchamber.com/bird-u-s-israel-binational-industrial-rd-foundation-invest-900000-novellusdx-christiana-care-gene-editing-institute-collaboration/

http://www.novellusdx.com/news/novellusdx-receives-1st-prize-in-the-international-quality-innovation-award-competition/